Hi Danagram, could you please elaborate on your comment; ‘The less news before FDA approval the better …’, my thinking is any sp sensitive news, via ASX, would be beneficial to the sp. Why: Mercer, future, entry points at a higher sp, any potential CR, at a higher sp, options and @ $8 ‘snapped’ up, that make sense?
CRs, Mercer entry points at North of current sp done at a higher sp?, sentiment factor in lead up too FDA approval?
Imo, not advice.
Watchthisspace tweet, page-59
-
- There are more pages in this discussion • 143 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.35 |
Change
0.150(0.87%) |
Mkt cap ! $333.5M | |||
| Open | High | Low | Value | Volume |
| $17.19 | $17.39 | $16.90 | $350.7K | 20.39K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 66 | $17.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.50 | 500 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |